Lawson, Daryl; Lee, Kevin H.; Kang, Hyun Bin; Yang, Nan; Llewellyn, Tracy; Takamatsu, Shozo. Clinical rehabilitation 2021; 35(3): 390β398
Kurz erklΓ€rt
The study investigated whether a microcurrent device (a device that emits very weak electrical currents) helps with acute knee pain. Over a four-week period, pain levels decreased significantly more in the microcurrent group than in the placebo group. The difference was particularly clear after the third week (P < 0.01). Physical function also showed a tendency to improve among participants using microcurrent therapy by the third week. Fifty-two adults took part, wearing the device for three hours a day at home for four weeks.
Γbertragbarkeit auf den HD2000+
Stufe B Vergleichbare Parameter
Comparable parameters
FΓΌr Fachleute
In this randomised, double-blind, placebo-controlled trial, 52 participants (35 women, 17 men) with acute knee pain were evenly divided into a treatment group (n = 26) and a placebo group (n = 26). Both groups wore the respective device at home for 3 hours a day over a period of 4 weeks. The primary endpoints were the Numeric Pain Rating Scale (NPRS) and the Short Form 12 (SF-12); secondary outcomes included musculoskeletal ultrasound and the Lower Extremity Functional Scale (LEFS). All 52 participants completed the study. Microcurrent therapy significantly reduced pain over the 4-week period, particularly in week 3 (P < 0.01 after correction for multiple testing). In the SF-12, the active treatment group showed an upward trend in physical functioning scores up to week 3. The authors conclude that the active device reduced knee pain and improved function.
Originalstudie ΓΆffnen (DOI) PubMed
Bewertungsgrundlage: Volltext geprΓΌft Β· zuletzt geprΓΌft am 18 Nov 2026. Diese Datenbank informiert ΓΌber verΓΆffentlichte Forschung. Sie ersetzt keine Γ€rztliche Beratung und ist kein Wirksamkeitsversprechen. Die Einordnung stammt von der LuXXaMed GmbH als Hersteller des HD2000+.
